Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aclidinium/formoterol versus tiotropium for hyperinflation in COPD over 24 hours
2016-003989-12Phase 4Active
- Sponsor
- CIRO
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Aclidinium bromide + formoterol fumarate with Tiotropium Respimat (2 arms). Primary endpoint: Static hyperinflation over 24 hours. Started May 2017; status: active.
02
Drugs
aclidiniumformoteroltiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2016-003989-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003989-12.